Mirum Pharmaceuticals (MIRM) Long-Term Investments (2019 - 2026)

Mirum Pharmaceuticals' Long-Term Investments history runs 6 years deep, the most recent figure standing at $34.4 million for Q1 2026.

• On a quarterly basis, Long-Term Investments rose 64.27% year-over-year to $34.4 million in Q1 2026; TTM through Mar 2026 was $34.4 million, a 64.27% increase from a year earlier, with the FY2025 full-year figure at $8.1 million, down 35.29% from the prior year.
• Long-Term Investments advanced to $34.4 million in Q1 2026 per MIRM's latest filing, from $8.1 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $34.4 million in Q1 2026 and bottomed at $2.5 million in Q3 2025.
• The 3-year median for Long-Term Investments is $14.8 million (2024), against an average of $15.2 million.
• Across the five-year window, Long-Term Investments plunged 73.5% in 2025 and jumped 64.27% in 2026, its largest moves.
• Year by year, Long-Term Investments stood at $12.5 million in 2024, then tumbled by 35.29% to $8.1 million in 2025, then surged by 323.85% to $34.4 million in 2026.
• Per Business Quant, the three latest MIRM Long-Term Investments figures stand at $34.4 million (Q1 2026), $8.1 million (Q4 2025), and $2.5 million (Q3 2025).